Investor Relations
Explore information about IDEAYA's business, strategy, pipeline, and financial performance, as well as the latest updates for the investment community.
Financial Information
Snapshot
This section of the IDEAYA Biosciences InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing.
Please note: All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes. IDEAYA Biosciences assumes no responsibility for the accuracy of this data and provides it for informational purposes only.
NASDAQIDYA
| Beta | (0.09) |
|---|---|
| Shares Outstanding | 87.9M |
| Average Volume (10 days) | 1.6M |
| Qtrly Dividend (Ann. Yield) | -- (--) |
Analyst Views
| Current Mean Recommendation | Strong Buy |
|---|
| Strong Buy | 13 | |
|---|---|---|
| Buy | 1 | |
| Hold | 3 | |
| Underperform | 0 | |
| Sell | 0 |
Recent Insider Transactions
Wendy Yarno Director | 20,000 Acquire Jun 16, 2026 |
|---|---|
Malcolm Garret Hampton Director | 20,000 Acquire Jun 16, 2026 |
Jeffrey Stein Director | 20,000 Acquire Jun 16, 2026 |
Terry Rosen Director | 20,000 Acquire Jun 16, 2026 |
Mackey Catherine Director | 20,000 Acquire Jun 16, 2026 |